Literature DB >> 15610927

Heroin abusers' performance on the Tower of London Test relates to the baseline EEG alpha2 mean frequency shifts.

Dmitry M Davydov1, Anna G Polunina.   

Abstract

Planning function deficit is the most consistent finding in neuropsychological studies of heroin addicts. The performance on the Tower of London Test (TLT) correlated with the duration of daily heroin abuse (DDHA) in our previous study. Alpha2 mean frequency in anterior/central derivations was also predicted by DDHA in the same patient population. This retrospective study was undertaken in order to understand better the relationships between observed neurological deviations in heroin abusers. Thirty-three heroin addicts and 12 healthy males were evaluated with 14 neuropsychological tests and resting eyes-closed electroencephalography (EEG). Multivariate tests showed that performance on the difficult (five-move) problems of TLT was strongly predicted by the EEG alpha2 mean frequency shifts, and these relationships were generally mediated by chronic heroin length. However, post-hoc analyses at separate leads demonstrated that the relationships between cognitive variables and alpha2 mean frequencies in the left hemisphere were independent of chronic heroin effects, whereas elevation of alpha2 frequency in the right hemisphere was strongly predicted by chronic heroin intake length. The patients with extremely high alpha2 mean frequency at the left central region were especially prone to failure in TLT due to the inability of the hypothesized alpha2-generating network, which normally projects to the central and temporal derivations bilaterally and to the right posterior temporal derivation to function appropriately. Hence, it was concluded that planning dysfunction in heroin abusers is related to alpha2 mean frequency shifts predominantly at the central regions.

Entities:  

Mesh:

Year:  2004        PMID: 15610927     DOI: 10.1016/j.pnpbp.2004.06.006

Source DB:  PubMed          Journal:  Prog Neuropsychopharmacol Biol Psychiatry        ISSN: 0278-5846            Impact factor:   5.067


  8 in total

Review 1.  Are executive function and impulsivity antipodes? A conceptual reconstruction with special reference to addiction.

Authors:  Warren K Bickel; David P Jarmolowicz; E Terry Mueller; Kirstin M Gatchalian; Samuel M McClure
Journal:  Psychopharmacology (Berl)       Date:  2012-03-24       Impact factor: 4.530

2.  Prefrontal and temporal gray matter density decreases in opiate dependence.

Authors:  In Kyoon Lyoo; Mark H Pollack; Marisa M Silveri; Kyung Heup Ahn; Claudia I Diaz; Jaeuk Hwang; Seog Ju Kim; Deborah A Yurgelun-Todd; Marc J Kaufman; Perry F Renshaw
Journal:  Psychopharmacology (Berl)       Date:  2005-12-21       Impact factor: 4.530

3.  Increased local and decreased remote functional connectivity at EEG alpha and beta frequency bands in opioid-dependent patients.

Authors:  Andrew A Fingelkurts; Alexander A Fingelkurts; Reetta Kivisaari; Taina Autti; Sergei Borisov; Varpu Puuskari; Olga Jokela; Seppo Kähkönen
Journal:  Psychopharmacology (Berl)       Date:  2006-07-19       Impact factor: 4.530

4.  Acute effects of methadone on EEG power spectrum and event-related potentials among heroin dependents.

Authors:  Farid Motlagh; Fatimah Ibrahim; Rusdi Rashid; Niusha Shafiabady; Tahereh Seghatoleslam; Hussain Habil
Journal:  Psychopharmacology (Berl)       Date:  2018-10-11       Impact factor: 4.530

Review 5.  Factors mediating pain-related risk for opioid use disorder.

Authors:  Arbi Nazarian; S Stevens Negus; Thomas J Martin
Journal:  Neuropharmacology       Date:  2021-01-30       Impact factor: 5.250

6.  Addiction history moderates the effect of prefrontal 10-Hz transcranial alternating current stimulation on habitual action selection.

Authors:  Theresa H McKim; Samantha J Dove; Donita L Robinson; Flavio Fröhlich; Charlotte A Boettiger
Journal:  J Neurophysiol       Date:  2020-12-23       Impact factor: 2.714

7.  Personalized behavior management as a replacement for medications for pain control and mood regulation.

Authors:  Dmitry M Davydov; Carmen M Galvez-Sánchez; Casandra Isabel Montoro; Cristina Muñoz Ladrón de Guevara; Gustavo A Reyes Del Paso
Journal:  Sci Rep       Date:  2021-10-13       Impact factor: 4.379

8.  The influence of levetiracetam in cognitive performance in healthy individuals: neuropsychological, behavioral and electrophysiological approach.

Authors:  Julio Cesar Magalhães; Mariana Gongora; Renan Vicente; Juliana Bittencourt; Guaraci Tanaka; Bruna Velasques; Silmar Teixeira; Gledys Morato; Luis F Basile; Oscar Arias-Carrión; Fernando A M S Pompeu; Mauricio Cagy; Pedro Ribeiro
Journal:  Clin Psychopharmacol Neurosci       Date:  2015-04-30       Impact factor: 2.582

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.